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Abstract
Introduction: Many intensive care patients experience sleep disruption potentially related to noise, light and
treatment interventions. The purpose of this study was to characterise, in terms of quantity and quality, the sleep
of intensive care patients, taking into account the impact of environmental factors.
Methods: This observational study was conducted in the adult ICU of a tertiary referral hospital in Australia,
enrolling 57 patients. Polysomnography (PSG) was performed over a 24-hour period to assess the quantity (total
sleep time: hh:mm) and quality (percentage per stage, duration of sleep episode) of patients’ sleep while in ICU.
Rechtschaffen and Kales criteria were used to categorise sleep. Interrater checks were performed. Sound pressure
and illuminance levels and care events were simultaneously recorded. Patients reported on their sleep quality in
ICU using the Richards Campbell Sleep Questionnaire and the Sleep in Intensive Care Questionnaire. Data were
summarised using frequencies and proportions or measures of central tendency and dispersion as appropriate and
Cohen’s Kappa statistic was used for interrater reliability of the sleep data analysis.
Results: Patients’ median total sleep time was 05:00 (IQR: 02:52 to 07:14). The majority of sleep was stage 1 and 2
(medians: 19 and 73%) with scant slow wave and REM sleep. The median duration of sleep without waking was
00:03. Sound levels were high (mean Leq 53.95 dB(A) during the day and 50.20 dB(A) at night) and illuminance
levels were appropriate at night (median <2 lux) but low during the day (median: 74.20 lux). There was a median
1.7 care events/h. Patients’ mean self-reported sleep quality was poor. Interrater reliability of sleep staging was
highest for slow wave sleep and lowest for stage 1 sleep.
Conclusions: The quantity and quality of sleep in intensive care patients are poor and may be related to noise,
critical illness itself and treatment events that disturb sleep. The study highlights the challenge of quantifying sleep
in the critical care setting and the need for alternative methods of measuring sleep. The results suggest that a
sound reduction program is required and other interventions to improve clinical practices to promote sleep in
intensive care patients.
Trial registration: Australian New Zealand clinical trial registry (http://www.anzctr.org.au/): ACTRN12610000688088.
Introduction
The role of good quality sleep in health is well known
[1,2]. However, many critically ill patients treated in the
intensive care unit (ICU) experience sleep disruption [3-6].
Intensive care patients may experience normal or near-
normal total sleep time (TST) but have been reported to
have reduced slow wave (SW) and rapid eye movement
(REM) sleep, largely because of frequent arousals. The fac-
tors causing sleep disruption in intensive care patients are
not fully understood; many extrinsic and intrinsic factors
have been proposed, such as noise [7], light, inflammatory
mediators [6], sedative and opioid medications [4] and
mechanical ventilator settings [8]. Polysomnography (PSG)
recording is supported by reports from ICU patients on
their inability to sleep well in ICU [9,10]. Patients often
attribute disturbances to their sleep to noise levels [10].
Twenty-four hour PSG studies in ICU have been few and
there are no recent studies; there have been fewer studies
still examining the prevalence of sleep disruptive factors
simultaneously with PSG or investigations of ICU patient
perceptions of the quality of sleep and sleep disruptions in
conjunction with PSG recording. The primary aim of this
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observational study was to provide a current assessment of
the quality and quantity of critically ill patients’ sleep while
they were treated in ICU. The secondary aims were to
explore the prevalence of the main factors that potentially
affect sleep in ICU, that is the environmental sound pres-
sure and illuminance levels ICU patients are exposed to,
and the frequency of treatment and care patients receive.
We also assessed self-reported sleep quality while patients
were treated in ICU and the hospital ward and patients’
perceptions of sleep disruptions in ICU.
Materials and methods
Study setting and sample
This study was conducted in a 36-bed adult general ICU
in a 600-bed hospital in Sydney, Australia. The ICU pro-
vided specialty services such as cardiac, spinal, burns and
renal and was a closed unit with an accredited intensivist
responsible for the management of all patients. Ward
rounds were conducted by the intensivist twice a day
when treatment goals/plans were reviewed, for example
sedation medication prescriptions were adjusted according
to the individual patient needs (routinely, calm and inter-
active). The registered nurse (RN) to patient ratio was 1:1
for mechanically ventilated patients and 1:2 for patients
requiring high dependency care. There was no distinct
area for the care of high dependency level patients;
mechanically ventilated patients were cared for alongside
patients of lower acuity. The RN performed all the nursing
care for the patient. The main practices associated with
sleep promotion during the time in which the study was
conducted were offering a night-time hypnotic (that is,
temazepam) and earplugs/eye shades to the patients and
dimming the main lights at night.
Patients were included if aged >16 years and likely to be
treated in ICU for >24 hours and able to give informed
consent on their own behalf. The ability to provide con-
sent was assessed by the following means: i) subjective
advice by the bedside nurse; cognition was discussed
including orientation to time and place and ability to fol-
low simple instructions; ii) the patient was approached
and asked to state their name (or mouth the words); if the
patient was able to perform this instruction a further
check was made; iii) the patient’s understanding and ability
to follow instructions was checked by asking them to nod
when the correct colour card was held up from a selection
of three. Exclusion criteria included a history of sleep dis-
orders, psychiatric illness requiring medication, a known
diagnosis of dementia or central neurological impairment
confirmed by radiological scan. Human Research Ethics
Committee approval for the study was provided by the
Health Service and the University of Technology Sydney.
Patients provided informed consent with written confir-
mation by their next of kin in cases where the patient was
unable to sign the consent form. Data were collected from
January to December, 2009 and September 2010 to April
2011. Screening for eligibility was performed on weekdays.
Data collection
On enrolment, patients rated their sleep quality prior to
hospitalization using a 1 to 10 scale (10 = excellent) and
patients or their proxy completed the Insomnia Severity
Index (ISI) [11]. The ISI comprises seven items based
on the symptoms and severity of sleep disturbance; each
item is scored from 0 (not at all) to 4 (extremely). The
total ISI score ranges from 0 to 28 with a cutoff for clin-
ical insomnia of 15. Concurrent validity with a sleep
diary has been reported at r = 0.65 [11].
Patients were monitored for one 24-hour period using a
portable PSG device, either PS-2™ (Compumedics, Mel-
bourne, Australia) or ALICE LE™ (Philips Respironics,
Amsterdam, Netherlands). Recording began and finished
between 1000 and 1700 hours. Electroencephalograph
(EEG) (O1/M2, C4/M1), electromyograph (EMG), electro-
oculograph (EOG) (right and left) and electrocardiograph
(ECG) (lead II) were recorded. Patients’ skin was prepared
according to standard techniques. Gold cup EEG electro-
des were placed at O1/M2 and C4/M1 according to the
International 10-20 System [12]. Two EOG electrodes
were used for right and left eye movements. The EMG
electrodes were located over the right and left masseter
(facial) muscles. Electrode application was performed by
the authors (RE and MF) who were both trained in the
technique. Electrode impedance was maintained <9,000
ohms. Visual checks were performed hourly and electro-
des were replaced if impedance values approached 9,000
ohms or when the patient was disturbed for routine
repositioning.
Sound and illuminance levels were recorded simulta-
neously with PSG using the integrated sound pressure
level meter (model 2250, Brüel and Kjaer™, Nærum,
Denmark) and illuminance level meter (T-10, Konica
Minolta™, Osaka, Japan). Continuous equivalent sound
pressure levels (Leq) in ‘A’ weighted decibels and peak
sound pressure levels (Lpeak) in ‘C’ weighted decibels
were logged every second. More detailed information
about the protocol for sound pressure level recording
and configuration of patient rooms is reported elsewhere
[13]. Illuminance level (in lux) was recorded, using a sen-
sor placed close to the patient’s head, once per minute.
The bedside nurse was requested to log an event when-
ever the patient received treatment or care using a spe-
cially designed Microsoft Access™ (Microsoft, Redmond,
WA, USA) form listing a number of events on a compu-
ter located within reach. The event log contained the fol-
lowing items: clinical assessment; tracheal suctioning;
pressure area care; physiotherapy; mouth/eye care; blood
test (sampling); wash; non-invasive blood pressure; eating
and drinking; dressing; pain; line insertion; X-ray; clinical
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crisis; agitation/anxiety/confusion; electrode replacement
and other (for example placing an extra blanket on the
patient).
On completion of PSG recording patients rated their
previous night’s sleep using the Richards Campbell Sleep
Questionnaire (RCSQ) [14]. The RCSQ contains five
100mm visual analogue scales (VAS): sleep depth,
latency, awakenings, time awake and quality of sleep
(higher scores indicate better sleep). The RCSQ was pilot
tested in a medical ICU [15] and validated with overnight
PSG in medical ICU patients [14]. In our study, patients
who were unable to write were assisted; the patient used
their current communication strategy to indicate where
the investigator should mark the VAS.
One to two nights after transfer to the ward, patients
rated their sleep on the ward using the RCSQ and
reported on sleep-disturbing factors in ICU using the
Sleep in Intensive Care Questionnaire (SICQ) [10]. The
SICQ was developed to determine the perceived effect of
the ICU environment on sleep. It contains seven questions
(rated 1 to 10), including overall sleep quality at home,
sources of perceived sleep disruption and sources of noise.
Demographic and clinical data were collected from the
patient’s record. The Acute Physiology and Chronic
Health Evaluation (APACHE) III modified diagnostic
codes [16] were used to classify diagnoses. The APACHE
II severity of illness score on admission and the Modified
Sequential Organ Failure Assessment (SOFA) [17] at the
time of enrolment were calculated to assess severity of
illness.
Data analysis
Polysomnography recordings were scored manually in 30-
second epochs, by three qualified sleep technologists using
standard Rechtschaffen and Kales [18] (R and K) criteria.
TST was defined as the time spent in all sleep stages. The
percentage of time in each sleep stage and sleep during
the day (0600 to 2100 hours) was calculated. Arousals
were defined using American Academy of Sleep Medicine
criteria [19] and the number per hour of sleep (arousal
index) reported. Morphine equivalent doses of opioid
medications [20] and midazolam equivalent doses of ben-
zodiazepine [21] were calculated to summarise the doses
of opioid and sedative medications administered.
The software packages PASW™ (version 18; SPSS Inc,
Chicago, IL, USA) and Microsoft Excel (2007) were used
to analyse the data. Means and medians were used to
describe continuous data and frequencies and percentages
were used for categorical data. Interrater reliability for
scoring the PSG data by sleep technologists was performed
on 16 (30%) recordings using Cohen’s Kappa statistic. The
Mann-Whitney U test was used to detect differences
between the TST and arousal indices for patients who
received mechanical ventilation during PSG and those
who did not and to compare arousal indices for patients
who received benzodiazepine medications or propofol and
those who did not. The correlation between arousal
indices and peak sounds (>80 dB(A)) was explored using
Pearson’s r. Wilcoxon signed ranks test was used to com-




During the study twenty-four hour PSG data were ana-
lysed for 53 patients and 47 patients were followed up on
the ward. Of 266 eligible patients 57 were enrolled; of
those not enrolled 74 declined participation and 135 were
transferred to the ward before they could be invited to
participate. Two patients requested removal of PSG after
recording began, palliation was initiated for another and
data for another was unable to be analysed. Figure 1 pro-
vides a flow diagram of the number of eligible patients and
the number invited to participate and enrolled. The char-
acteristics of patients enrolled in the study are provided in
Table 1. Admission diagnoses were mostly non-operative
(66%), mean APACHE II score was 18.70 (SD: 8.23) and
the mean SOFA score was 4.04 (SD: 2.53). Patients were
interactive and calm (mean Vancouver Interaction Scale
(VICS) [22] score: 27.06 (SD: 3.80) (equivalent to 0 or -1
on the Richmond Agitation Sedation Scale (RASS) [23]).
Twenty-one percent of patients reported a pre-hospital
ISI score of ≥15, indicating moderate to severe clinical
insomnia, however, median pre-hospitalisation sleep
quality on the SICQ was 8.00 out of 10.00. There was no
difference between the mean RCSQ score in ICU and on
the ward (P = 0.61). Noise was rated the highest sleep-
disturbing factor (Table 2).
Sleep, sound and light
Median TST was five hours (Figure 2). The median dura-
tion of sleep without waking was 00:03 (hh:mm). Unusual
sleep stage transitions were noted (for example progres-
sion from stage 1 to REM sleep). Daytime sleep comprised
41% of TST and EEG delta wave activity was observed
when patients were interactive and apparently awake. The
majority of sleep was stages 1 and 2 (19 and 73 %, respec-
tively). SW and REM sleep was scant (median (IQR) 0 (0
to 1) and 0 (0 to 6) respectively). Arousals were frequent
(median arousal index: 27) (Table 3). Interrater reliability
of the sleep technologists’ PSG analysis for sleep/awake
was 0.58 to 0.68 (Table 4).
Sound pressure levels were high (mean Leq 53.95 (SD:
2.33) dB(A) during the day and 50.20 (SD: 3.21) dB(A)
at night). There were a median 416/h sound peaks >80
dB(C) during the day and 90/h at night. The correlation
between arousal indices and number of sound peaks
>80 dB(A) was weak during the day (r = 0.13) and night
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(r = 0.19); neither was statistically significant. Median
illuminance levels were lower at night (1.74 lux) than
during the day (74.20 lux). The average number of care
events was 1.74/h; the lowest was between 0200 and
0500 hours (<1.00/h). No patients wore ear plugs or eye
shades during sleep monitoring.
Sleep mechanical ventilation and medications
Pressure support was the ventilation mode used for 26
patients (six patients received pressure control ventila-
tion (PCV) for periods during pressure support), one
patient received synchronised intermittent ventilation


























Admissions = 2,433 
Satisfied inclusion criteria = 656 
Excluded = 390 (history 
of sleep disorder = 70; 
neurological impairment 
= 61; infectious = 117; 
other = 142) 
Eligible = 266 
Eligible not enrolled = 
209 (declined = 74; 
discharged before = 
135a) 
Patients followed up in hospital 
ward = 47 
Died = 3 
Lost to 
follow up = 
3 
24-hour sleep monitoring 
completed and analysed in 
ICU = 53 
Enrolled = 57 
24 hour sleep monitoring 
discontinued or data not 
analysed = 4 (Palliation/died = 1 
Wished to discontinue PSG = 2 
Unable to analyse data =1) 
Figure 1 Prevalence of eligible patients. Number of patients admitted to ICU during the time period in which the study was conducted,
eligible for the study, enrolled and completing 24-hour polysomnography (PSG) monitoring and sleep questionnaires on the hospital ward.
aEnrolment of eligible patients was limited by the availability of only one PSG and one researcher for the entire 24-hour recording period.
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patients were extubated (that is, had their endotracheal
tube removed) during PSG monitoring. The median
TST of patients who received mechanical ventilation
during PSG recording and those who did not was 05:14
(IQR: 03:36 to 07:57) vs. 03:57 (IQR: 01:39 vs. 06:47;
P = 0.049) and median arousal indices (20.50 IQR: 11.50
to 32.5 vs. 29.50 IQR: 22.00 to 40.87, P = 0.018). The
differences for other sleep parameters did not reach sta-
tistical significance for patients who received mechanical
ventilation during PSG recording and those who did not
(for example, stage 1: 22.87 (24.13) vs. 27.54 (19.85) %,
stage 2: 69.99 (24.02) vs. 67.30 (20.17) % and REM: 4.47
(5.90) vs. 2.38 (4.91) %).
The mean equivalent dose of morphine was 12.46 (SD:
24.42) mcg/kg/h and equivalent dose of midazolam was
2.26 (SD: 11.60) mcg/kg/h. Six patients received temaze-
pam (four received 20mg and two 10mg) for night seda-
tion. There was a difference in the median arousal indices
for patients who received benzodiazepine medication/pro-
pofol and those who did not (22.00 IQR: 11.25 to 31.75 vs.
30.00 IQR: 20.75 to 40.75; P = 0.019). The differences for
other sleep parameters did not reach statistical significance
for patients who received benzodiazepine medication/pro-
pofol and those who did not (for example, stage 1: 26.41
(20.74) vs. 23.71 (23.75) %, stage 2: 67.42 (19.38) vs. 69.97
(24.74) % and REM: 2.85 (4.76) vs. 4.14 (6.16) %).
Discussion
This study provides a current characterisation of the qual-
ity and quantity of sleep in intensive care patients, together
with factors that potentially affect the sleep of patients in
ICU. Sleep quality was poor; over 90% of patients’ sleep
was stage 1 and 2 and TST was below that experienced by
Table 1 Patient characteristics
Characteristics n = 53




Age, mean (SD)a, y 60.13 (20.02)
APACHEbII score, mean (SD) 18.70 (8.23)
SOFAcscore, mean (SD) 4.04 (2.53)
Sedation level on enrolment (VICSd), mean (SD)
Interaction score 27.06 (3.80)
Calmness score 29.00 (2.70)
BMIein kg/m2, mean (SD) 24.50 (4.90)
Duration of ventilation, median (IQRf), d 6.00 (1.67-21.50)
Length of ICU stay, median (IQR), d 12.00 (6.00-26.00)
Length of hospital, median (IQR), d 29.00 (17.50-49.50)
ICU admission day on which sleep monitoring occurred, median (IQR), d 5.00 (2.50-11.00)
Patients receiving mechanical ventilation during PSG, n (%) 28 (54)
Patients receiving an opioid, benzodiazepine or propofol, n (%) 43 (81)
Patients administered opioid and benzodiazepine medicationsg, n (%) 16 (30)
Patients administered benzodiazepine/propofol, n (%) 28 (53)
Patients administered opioids, n (%) 32 (60)
aSD, standard deviation; bAPACHE, Acute Physiology and Chronic Health Evaluation; cSOFA, Sequential Organ Failure Assessment; dVICS, Vancouver Interaction
Calmness Scale (I = interaction score 5-30, higher scores are desirable, C = calmness score 5-30, higher scores are desirable), eBMI, body mass index; fIQR,
interquartile range; gincluding propofol.
Table 2 Sleep outcomes: subjective reports
Outcomes Patients (n = 48)
ISIascore, median (IQRb) 6.00 (1.00-13.75)
ISI score ≥15, n (%) 10 (21)
Sleep quality pre-hospitalisation, median (IQR), 1-10 8.00 (5.00-9.00)
Patients (n = 40)
Total RCSQcscore in ICU, median (IQR), mm 57.50 (32.00-70.00)
Patients (n = 45)
Total RCSQ score in ward, median (IQR), mm 57.40 (36.70-74.40)d
Patients (n = 43)
Sleep disturbing factors (SICQe), mean (SDf), 1-10
Noise 5.70 (2.75)
Nursing interventions 5.05 (2.44)
Light 5.15 (2.61)
Diagnostic testing 4.49 (2.67)
Vital signs 4.25 (2.12)
Blood samples 4.01 (2.20)
Administration of medications 3.84 (2.12)
aISI, Insomnia Severity Index; bIQR, interquartile range = standard deviation;
cRCSQ, Richards Campbell Sleep Questionnaire; drelated samples Wilcoxon
signed ranks test comparing total RCSQ ICU and ward scores P = 0.61, eSICQ,
Sleep in Intensive Care Questionnaire; f SD, standard deviation.
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Figure 2 Boxplot of total sleep time (TST) (hh:mm:ss) for the sample. There was a large variation the TST for the sample.
Table 3 Sleep outcomes: PSG-derived data, sleep time and stages
Outcomes (n = 53)
Duration of PSG recording, median (IQR), hh:mm 24:00 (23:37-24:00)
TSTa, median (IQRb), hh:mm 05:00 (02:52-07:14)
Duration of sleep without waking, median (IQR), hh:mm 00:03 (00:02-00:05)
Number of sleep periods, median (IQR) 38.00 (19.00-56.50)
Sleep during daytime hours, median (IQR), % 41 (24-55)
Stage 1, median (IQR), hh:mm 01:00 (00:22-01:31)
Stage 1, median (IQR), % 19 (8-31)
Stage 2, median (IQR), hh:mm 03:03 (01:36-05:19)
Stage 2, median (IQR), % 73 (58-87)
Slow wave sleep, median (IQR), hh:mm 00:00 (00:00-00:04)c
Slow wave sleep, median (IQR), % 0 (0-1)c
REMd, median (IQR), hh:mm 00:00 (00:00-00:21)e
REM, median (IQR), % 0 (0-6)e
Arousals, median (IQR), No. per hr 27.00 (14.00-37.50)
aTST, total sleep time; bIQR, interquartile range; crange = 00:00-01:58, 0-39%; dREM, rapid eye movement; erange = 00:00-01:52, 0-22%.
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healthy adults. These results indicate that there has been
no improvement since studies published between 1976
and 2003 [3,5,24-26], despite improvements in ICU design,
technology and health care personnel training. Sleep frag-
mentation and unconventional architecture was evident
with multiple short, non-contiguous sleep periods and
numerous arousals. Arousals were frequent, as well as
non-sequential stage changes [4,27]. A large percentage of
TST was during daytime hours
Sound levels were elevated and exceeded World Health
Organization (WHO) standards for hospitals, that is Leq
should not >35 dB(A) in patient areas [28]. In our study,
Leq was >49 dB(A). Continuous equivalent sound pressure
levels were 10 dB(A) lower than in many studies in ICU
[5,29,30] but similar to others [26,31]. The frequency of
sound peaks >80 dB(C) was notable (range: 31 to 1,436/h)
and high in comparison with other studies. Kahn et al.
[32] reported a mean of 56/h before a noise reduction pro-
gram and 40/h afterwards, while the mean reported by
Meyer et al. [33] was 60/h. It is somewhat surprising that
there was no correlation between arousal indices and the
number of sound peaks >80 dB(A), although it is possible
that patients had become accustomed to high sound levels.
Illuminance levels were appropriate at night (median
<2 lux). However, daytime illuminance levels (74 lux) may
have been too low to encourage a 24-hour circadian
rhythm. Study of endogenous melatonin secretion in
healthy participants indicates that illuminance levels
of <100 lux may not be sufficiently bright to suppress
melatonin secretion in some individuals [34]. Thus
patients in our study may have had high melatonin levels
during the day that contributed to the proportion of day-
time sleep. The mean number of treatment/care events
was 40 (1.7/h). This contrasts with hourly rates reported
by others (for example 3, 7 and 6/h) [6,25,26]. Under-
recording by the bedside nurses may have occurred in our
study. While an attempt was made to record care events/
treatment in a synchronous manner, this proved difficult
in practice. Hence we are unable to draw conclusions
about the relationship between such events and arousals.
Medications administered and considered to potentially
affect sleep noted during PSG recording were mainly
opioids and sedative medications. A large proportion
(60%) of patients received opioid medications, potentially
affecting their sleep. SWS has been found to be reduced
by opioids, with a concomitant increase in stage 2 sleep
[35]. A large percentage of patients in our study received
benzodiazepines or propofol (53%) (however, only lightly
sedated patients were enrolled; the mean VICS score was
27.06 (SD: 3.80)). This may also have contributed to the
high proportion of stage 2 and lack of REM sleep [36].
However, it is notable that patients who received benzo-
diazepine medication or propofol had fewer arousals
than patients who did not. Despite the apparent suppres-
sion of SWS and REM, sleep may have been more conso-
lidated when sedative medications were administered.
The somewhat surprising findings that TST was higher
and there were fewer arousal indices in patients who
received mechanical ventilation during PSG recording
may be partly attributable to the larger sedative medica-
tion doses they received (mean: 3.49 (SD: 15.64) vs. 0.40
(SD: 0.75) mcg/kg/h).
Patients’ self-reports of sleep quality in ICU were poor
but comparable to previous studies. The mean RCSQ
score from patients ready for transfer to the ward in the
same ICU (n = 222) was 47.18 mm [37]. In a study investi-
gating the utility of the RCSQ and concordance of nurse
and patient sleep assessment in ICU, the mean RCSQ
score was 45.50 mm [38].
Patient perceptions of sources of sleep disruption were
similar to previous studies. Noise was rated the most dis-
ruptive, as has been reported elsewhere [26]. In the devel-
opment of the SICQ, ratings of disruptive activities were
lower and noise (4.5) was less disruptive than vital signs
(5.5) and phlebotomy (5.5) [10]. However, the SICQ was
first reported in 1999; non-invasive vital signs monitoring
and blood sampling in the current study would be
expected to be less disruptive than techniques in use in
the 1990s.
Study strengths and limitations
This study is the largest of its kind to be conducted using
PSG with simultaneous data collection for factors known
to affect sleep in ICU and is the first to present data from
the Australian context. In addition, other investigators
have rarely collected data on the patients’ perception of
Table 4 Interrater reliability (Cohen’s Kappa statistic) for Rechtschaffen and Kales scoring for sleep technologists (16
recordings)
Sleep stage/state Technologists one and two, 18,644 epochs (95% CIa) Technologists two and three, 25,908 epochs (95% CI)
Stage 1 0.12 (0.10-0.13) 0.08 (0.06-0.10)
Stage 2 0.58 (0.46-0.72) 0.55 (0.54-0.56)
Stage 3/4 0.76 (0.70-0.82) 0.20 (0.14-0.23)
REMb 0.44 (0.39-0.49) 0.41 (0.36-0.44)
Sleep/wake 0.68 (0.65-0.69) 0.58 (0.55-0.59)
aCI, confidence interval; bREM, rapid eye movement.
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sleep quality and potential sleep-disrupting factors in
conjunction with PSG recording. This subjective infor-
mation is vital in corroborating objective data, particu-
larly as sleep is a subjective experience.
A limitation that became evident during the study was
the difficulty in interpreting the PSG data using conven-
tional R and K analysis. One patient’s EEG waveform
was affected with ‘alpha intrusion’ (alpha wave activity
superimposed on delta waves), which made analysis
impossible (the likely explanation being the administra-
tion of antipsychotic medications after enrolment/PSG
recording began). Observation of EEG delta wave activ-
ity in some patients who appeared to be awake has been
noted in other studies [4,5,39]. Challenges in scoring
ICU patients’ sleep data were recently reported by
Drouot et al. [39] in their analysis of PSG data from
two studies conducted previously. The investigators
noted the presence of EEG delta wave activity during
apparent wakefulness (the presence of EMG, EOG and
limb activity) and a lack of K complexes and sleep spin-
dles preventing classification of stage 2. However, inter-
rater and intrarater scorer reliability checks were not
performed in that study.
Another limitation is the effect of benzodiazepine med-
ications on the interpretation of sleep parameters. It is
known that benzodiazepine medication increases EEG
beta wave activity and reduces EEG delta wave activity
[40]. Benzodiazepine medication also increases EEG spin-
dle activity [41] (though this appears not to have been the
case in our study). The combined effect of the opioids
and sedative medication on EEG activity likely affected
the results. However, since these medications are essen-
tial adjuncts in the treatment and comfort of many ICU
patients, excluding patients who received them would
have severely limited recruitment and the generalisability
of our results. Other limitations were the presence of fac-
tors such as the use of different modes of mechanical
ventilation and health conditions such as systemic
inflammatory response, but such factors are common in
ICU patients and their exclusion would also limit the
applicability of the results to the ICU patient population.
Patient enrolment was limited by a number of factors.
The availability of PSG monitoring equipment and the
principal researcher were the primary factors for patients
being discharged before they were approached to partici-
pate. For this study, we had access to only two people
trained in sleep recordings (RE and MF) and one portable
sleep-monitoring device, creating practical limitations to
the number and frequency of studies performed. In addi-
tion, there was often limited opportunity in which patients
were cognitively able to agree to participate before they
were discharged to the hospital ward. A large proportion
of patients approached about the study declined to partici-
pate; many considered the application of monitoring as a
set-back in their condition regardless of the reason for it.
This may limit the generalisability of the results to a sub-
set of patients treated in the study ICU.
Interrater reliability of the R and K analysis was moder-
ate, 0.56 for sleep technologists one and two and 0.51 for
sleep technologists two and three but lower than Kappa
values for sleep technologists in sleep investigation units
(for example 0.72 [42]). Interrater reliability for each stage
was also lower than in sleep laboratory studies. The relia-
bility of PSG analysis in ICU patients has been infrequently
reported. In one study of critically ill, non-ventilated
trauma patients’ night-time sleep, interrater reliability for
one overnight recording, was reported as Kappa = 0.82
[43]. However, in a comparison by Ambrogio et al. of four
methods of analysing ICU patients’ PSG data, interrater
reliability was considerably lower than in the present study
(Kappa = 0.19) [44].
Conclusions
The quantity and quality of patients’ sleep while in this
ICU using both objective and subjective assessment
methods were found to be poor. Given the similarity
between the sleep outcomes and prevalence of potential
sleep-disturbing factors in our study and previous stu-
dies, sleep disruption clearly remains a substantial pro-
blem for many ICU patients. Importantly, the current
study has added to evolving knowledge of the challenges
of using PSG in ICU and analysing the data. An alterna-
tive objective sleep assessment method is required for
ICU patients in order to further our understanding of
sleep disruption in this vulnerable patient population
and to test clinical interventions for their well-being and
recovery.
Key messages
·Sleep in ICU patients is highly fragmented with conco-
mitant deficiencies in SW and REM sleep.
·Use of PSG in ICU patients and analysing the data
are challenging.
·There is a need to develop alternative methods to
conventional PSG staging to measure sleep in ICU
patients and develop interventions which will improve
sleep.
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